| scholarly article | Q13442814 |
| P50 | author | Mamta Chawla-Sarkar | Q61771491 |
| P2093 | author name string | Dhananjaya V Kalvakolanu | |
| Jiadi Hu | |||
| Bendi Gong | |||
| Joseph A Bauer | |||
| Daniel J Lindner | |||
| Alex Almasan | |||
| Bei H Morrison | |||
| Aylin M Ozdemir | |||
| Ronald W Grane | |||
| P2860 | cites work | Synthesis of diphosphoinositol pentakisphosphate by a newly identified family of higher inositol polyphosphate kinases | Q22010845 |
| Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells | Q24291206 | ||
| Inositol polyphosphate multikinase (ArgRIII) determines nuclear mRNA export in Saccharomyces cerevisiae | Q27936942 | ||
| A phospholipase C-dependent inositol polyphosphate kinase pathway required for efficient messenger RNA export | Q27938472 | ||
| Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies | Q28142083 | ||
| TRAIL receptor-2 signals apoptosis through FADD and caspase-8 | Q28142998 | ||
| Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL | Q28250747 | ||
| Induction of apoptosis and inhibition of cell growth are independent responses to interferon-alpha in hematopoietic cell lines | Q28305124 | ||
| FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2 | Q28609079 | ||
| Binding of inositol phosphate to DNA-PK and stimulation of double-strand break repair | Q28646559 | ||
| Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors | Q29547463 | ||
| New colorimetric cytotoxicity assay for anticancer-drug screening | Q29615418 | ||
| Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo. | Q34086453 | ||
| Inositol hexakisphosphate binds to clathrin assembly protein 3 (AP-3/AP180) and inhibits clathrin cage assembly in vitro | Q34315447 | ||
| Inhibition of clathrin assembly by high affinity binding of specific inositol polyphosphates to the synapse-specific clathrin assembly protein AP-3. | Q38299578 | ||
| Transcriptional activation of TRADD mediates p53-independent radiation-induced apoptosis of glioma cells | Q40796980 | ||
| Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines. | Q40798570 | ||
| Effect of ultraviolet light, methyl methanesulfonate and ionizing radiation on the genotoxic response and apoptosis of mouse fibroblasts lacking c-Fos, p53 or both | Q40810117 | ||
| Transfer of human chromosome 3 to an ovarian carcinoma cell line identifies three regions on 3p involved in ovarian cancer | Q41415869 | ||
| Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines. | Q41609796 | ||
| Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. | Q41747264 | ||
| Structural identification of the myo-inositol 1,4,5-trisphosphate-binding domain in rat brain inositol 1,4,5-trisphosphate 3-kinase | Q42159660 | ||
| Arrestin function in G protein-coupled receptor endocytosis requires phosphoinositide binding | Q42667054 | ||
| Irradiation of mitochondria initiates apoptosis in a cell free system | Q43583342 | ||
| Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene | Q43624125 | ||
| Inositol hexakisphosphate receptor identified as the clathrin assembly protein AP-2 | Q43913945 | ||
| Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer | Q48084125 | ||
| Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells. | Q54008325 | ||
| Thymocyte apoptosis induced by p53-dependent and independent pathways. | Q54242475 | ||
| Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies | Q56421857 | ||
| Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer | Q59079930 | ||
| Clinical usefulness of thyroid-stimulating antibody measurement using Chinese hamster ovary cells expressing human thyrotropin receptors | Q71937889 | ||
| Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells | Q73144184 | ||
| Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis | Q73540307 | ||
| Binding kinetics and ligand specificity for the interactions of the C2B domain of synaptogmin II with inositol polyphosphates and phosphoinositides | Q74138378 | ||
| Induction of multiple programmed cell death pathways by IFN-beta in human non-small-cell lung cancer cell lines | Q74520572 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian carcinoma | Q18556145 |
| P304 | page(s) | 1882-9 | |
| 1882-1889 | |||
| P577 | publication date | 2002-03-01 | |
| 2002-03-14 | |||
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics | |
| P478 | volume | 21 |
| Q40474530 | Apo2L/TRAIL induction and nuclear translocation of inositol hexakisphosphate kinase 2 during IFN-beta-induced apoptosis in ovarian carcinoma. |
| Q28176737 | Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy |
| Q36835730 | Cigarette smoke (CS) and nicotine delay neutrophil spontaneous death via suppressing production of diphosphoinositol pentakisphosphate |
| Q39963975 | Combination treatment of human umbilical cord matrix stem cell-based interferon-beta gene therapy and 5-fluorouracil significantly reduces growth of metastatic human breast cancer in SCID mouse lungs |
| Q33349358 | DNA damage response and apoptosis. |
| Q37268113 | Diphosphoinositol polyphosphates: metabolic messengers? |
| Q24670467 | Effect of inositol hexakisphosphate kinase 2 on transforming growth factor beta-activated kinase 1 and NF-kappaB activation |
| Q36497226 | Gene deletion of inositol hexakisphosphate kinase 1 reveals inositol pyrophosphate regulation of insulin secretion, growth, and spermiogenesis |
| Q35208535 | Gene deletion of inositol hexakisphosphate kinase 2 predisposes to aerodigestive tract carcinoma |
| Q36446083 | HSP90 regulates cell survival via inositol hexakisphosphate kinase-2. |
| Q34558610 | IFN-zeta/ limitin: a member of type I IFN with mild lympho-myelosuppression. |
| Q33893410 | IP6K gene identification in plant genomes by tag searching. |
| Q59604012 | Inositol Pyrophosphates: Energetic, Omnipresent and Versatile Signalling Molecules |
| Q41830941 | Inositol hexakisphosphate kinase 1 regulates neutrophil function in innate immunity by inhibiting phosphatidylinositol-(3,4,5)-trisphosphate signaling |
| Q34366232 | Inositol hexakisphosphate kinase-2, a physiologic mediator of cell death |
| Q41820993 | Inositol hexakisphosphate kinases induce cell death in Huntington disease |
| Q33939404 | Inositol polyphosphate multikinase is a coactivator of p53-mediated transcription and cell death |
| Q37186675 | Inositol pyrophosphates and their unique metabolic complexity: analysis by gel electrophoresis |
| Q36886772 | Inositol pyrophosphates as mammalian cell signals |
| Q33570316 | Inositol pyrophosphates mediate the DNA-PK/ATM-p53 cell death pathway by regulating CK2 phosphorylation of Tti1/Tel2 |
| Q45926680 | Inositol pyrophosphates modulate hydrogen peroxide signalling. |
| Q38110945 | Inositol pyrophosphates: between signalling and metabolism |
| Q37588509 | Inositol pyrophosphates: structure, enzymology and function |
| Q35675514 | Interferon targeted genes in host defense |
| Q27010207 | Interferons as inducers of apoptosis in malignant cells |
| Q30881749 | Localization of TRAIL/TRAILR in fetal pancreas |
| Q36608654 | Newly established tumourigenic primary human colon cancer cell lines are sensitive to TRAIL-induced apoptosis in vitro and in vivo |
| Q34305020 | Obesity and cancer risk: evidence, mechanisms, and recommendations |
| Q45903193 | PPIP5K1 Suppresses Etoposide-triggered Apoptosis. |
| Q26786441 | The emerging roles of inositol pyrophosphates in eukaryotic cell physiology |
| Q26851038 | The enzymes of human diphosphoinositol polyphosphate metabolism |
| Q47250401 | The inositol pyrophosphate pathway in health and diseases |
| Q37805097 | The signaling role of inositol hexakisphosphate kinases (IP6Ks) |
| Q34397020 | p53-mediated apoptosis requires inositol hexakisphosphate kinase-2 |
Search more.